Bone marrow-derived mesenchymal stem cells (MSCs) have successfully progressed to phase III clinical trials successive to an intensive in vitro and pre-clinical assessment in experimental animal models of ischemic myocardial injury. With scanty evidence regarding their cardiogenic differentiation in the recipient patients’ hearts post-engraftment, paracrine secretion of bioactive molecules is being accepted as the most probable underlying mechanism to interpret the beneficial effects of cell therapy. Secretion of small non-coding microRNA (miR) constitutes an integral part of the paracrine activity of stem cells, and there is emerging interest in miRs’ delivery to the heart as part of cell-free therapy to exploit their integral role in various cellular processes. MSCs also release membrane vesicles of diverse sizes loaded with a wide array of miRs as part of their paracrine secretions primarily for intercellular communication and to shuttle genetic material. Exosomes can also be loaded with miRs of interest for delivery to the organs of interest including the heart, and hence, exosome-based cell-free therapy is being assessed for cell-free therapy as an alternative to cell-based therapy. This review of literature provides an update on cell-free therapy with primary focus on exosomes derived from BM-derived MSCs for myocardial repair.

Mircrining the injured heart with stem cellderived exosomes: an emerging strategy of cell-free therapy / Haider, Kh; Aramini, B.. - In: JOURNAL OF STEM CELL RESEARCH AND THERAPY. - ISSN 2157-7633. - 11:23(2020), pp. 1-12. [10.1186/s13287-019-1548-7]

Mircrining the injured heart with stem cellderived exosomes: an emerging strategy of cell-free therapy.

Aramini B.
Writing – Original Draft Preparation
2020

Abstract

Bone marrow-derived mesenchymal stem cells (MSCs) have successfully progressed to phase III clinical trials successive to an intensive in vitro and pre-clinical assessment in experimental animal models of ischemic myocardial injury. With scanty evidence regarding their cardiogenic differentiation in the recipient patients’ hearts post-engraftment, paracrine secretion of bioactive molecules is being accepted as the most probable underlying mechanism to interpret the beneficial effects of cell therapy. Secretion of small non-coding microRNA (miR) constitutes an integral part of the paracrine activity of stem cells, and there is emerging interest in miRs’ delivery to the heart as part of cell-free therapy to exploit their integral role in various cellular processes. MSCs also release membrane vesicles of diverse sizes loaded with a wide array of miRs as part of their paracrine secretions primarily for intercellular communication and to shuttle genetic material. Exosomes can also be loaded with miRs of interest for delivery to the organs of interest including the heart, and hence, exosome-based cell-free therapy is being assessed for cell-free therapy as an alternative to cell-based therapy. This review of literature provides an update on cell-free therapy with primary focus on exosomes derived from BM-derived MSCs for myocardial repair.
2020
11
23
1
12
Mircrining the injured heart with stem cellderived exosomes: an emerging strategy of cell-free therapy / Haider, Kh; Aramini, B.. - In: JOURNAL OF STEM CELL RESEARCH AND THERAPY. - ISSN 2157-7633. - 11:23(2020), pp. 1-12. [10.1186/s13287-019-1548-7]
Haider, Kh; Aramini, B.
File in questo prodotto:
File Dimensione Formato  
Haider Aramini review article.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 726.96 kB
Formato Adobe PDF
726.96 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1187345
Citazioni
  • ???jsp.display-item.citation.pmc??? 18
  • Scopus 54
  • ???jsp.display-item.citation.isi??? 30
social impact